ClinicalTrials.Veeva

Menu
A

Arkansas Cardiology | Little Rock

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relugolix
Etripamil
Methotrexate
Droxidopa
IONIS-AGT-LRx
Ranolazine
Evolocumab
TNX-102

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 22 total trials

Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke (VESALIUS-CV)

This study will assess the effect of lowering low-density lipoprotein cholesterol (LDL-C) with evolocumab on major cardiovascular events in adults wi...

Active, not recruiting
Coronary Heart Disease (CHD)
Drug: Evolocumab
Drug: Placebo

The objective of this study is to establish reasonable assurance of safety, effectiveness, and noninferiority of the Encore PFO closure device when c...

Enrolling
Cryptogenic Stroke
Patent Foramen Ovale
Device: Encore PFO closure device
Device: FDA-approved PFO closure device
Locations recently updated

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided hea...

Enrolling
Coronary Artery Disease
Left Ventricular Dysfunction
Device: Impella CP® / Impella CP® with SmartAssist® / Impella 2.5®
Device: IABP Intra-aortic balloon pump

The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...

Enrolling
Chronic Kidney Diseases
Hypertension
Device: Renal Denervation (Symplicity Spyral™)

Trial sponsors

Abbott logo
Amgen logo
M
M
Tonix Pharmaceuticals logo
University of Rochester logo
Abiomed logo
C
E
Ionis Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems